Oncothyreon Announces Presentations at Upcoming Investment Conferences in September

SEATTLE, Sept. 3, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will be presenting at the following investment conferences in September.

Rodman & Renshaw 15^th Annual Healthcare Conference
Tuesday, September 10, 2013, at 10 a.m. Eastern time in New York, NY

Stifel Nicolaus 2013 Healthcare Conference
Thursday, September 12, 2013, at 2:40 p.m. Eastern time in Boston, MA

A live and archived webcast of each presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.